Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1oral obesity drugsobesity

New Weight-Loss Pills Curb Snacking Less Than GLP-1 Injections

Bloomberg reports oral obesity drugs show weaker effects on snacking behavior than established injectable GLP-1 therapies.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 00:04 ETSource: Bloomberg.com

The wire

  1. 01Bloomberg reported that emerging weight-loss pills reduce snacking less than GLP-1 shots.
  2. 02Oral formulations are central to the next phase of obesity drug competition and pricing.
  3. 03Underlying data, specific drugs and comparative trial details were not given in the excerpt.

From the source

New Weight-Loss Pills Curb Snacking Less Than GLP-1 Shots

Read at news.google.com